Rosemarie Schmandt

7.5k total citations · 2 hit papers
65 papers, 4.6k citations indexed

About

Rosemarie Schmandt is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Rosemarie Schmandt has authored 65 papers receiving a total of 4.6k indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Molecular Biology, 21 papers in Oncology and 16 papers in Cancer Research. Recurrent topics in Rosemarie Schmandt's work include Endometrial and Cervical Cancer Treatments (11 papers), Cancer, Lipids, and Metabolism (9 papers) and Metabolism, Diabetes, and Cancer (8 papers). Rosemarie Schmandt is often cited by papers focused on Endometrial and Cervical Cancer Treatments (11 papers), Cancer, Lipids, and Metabolism (9 papers) and Metabolism, Diabetes, and Cancer (8 papers). Rosemarie Schmandt collaborates with scholars based in United States, Canada and Taiwan. Rosemarie Schmandt's co-authors include Karen H. Lu, Anil K. Sood, Michaela Onstad, Charles N. Landen, Gabriel Lopez‐Berestein, Michael T. Deavers, Arturo Chávez‐Reyes, Corazon D. Bucana, Gordon B. Mills and David A. Iglesias and has published in prestigious journals such as Journal of Biological Chemistry, Nature Communications and Journal of Clinical Oncology.

In The Last Decade

Rosemarie Schmandt

65 papers receiving 4.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Exosomal transfer of stroma-derived miR21 confers paclitaxel resistance in ovarian cancer cells through targeting APAF1

2016 622 citations Chi Lam Au Yeung, Tsz-Lun Yeung et al. Nature Communications profile →
Addressing the Role of Obesity in Endometrial Cancer Risk, Prevention, and Treatment

2016 400 citations Michaela Onstad, Rosemarie Schmandt et al. Journal of Clinical Oncology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Rosemarie Schmandt United States	32	2.7k	1.3k	1.1k	735	566	65	4.6k
Julie K. Schwarz United States	37	2.1k 0.8×	1.1k 0.9×	1.6k 1.4×	528 0.7×	1.0k 1.9×	134	5.0k
Elisabeth Müller‐Holzner Austria	38	2.1k 0.8×	962 0.7×	1.5k 1.3×	506 0.7×	353 0.6×	99	4.3k
Akihiro Nawa Japan	33	1.5k 0.6×	614 0.5×	1.5k 1.3×	720 1.0×	418 0.7×	111	3.8k
Kiyosumi Shibata Japan	41	2.1k 0.8×	994 0.8×	2.2k 1.9×	1.4k 1.9×	852 1.5×	195	5.9k
Miguel Abal Spain	34	1.7k 0.6×	882 0.7×	1.1k 1.0×	263 0.4×	381 0.7×	83	3.1k
Heidi Fiegl Austria	42	4.0k 1.5×	1.6k 1.2×	1.5k 1.3×	386 0.5×	224 0.4×	111	6.0k
Delia Mezzanzanica Italy	37	2.0k 0.7×	889 0.7×	1.3k 1.1×	472 0.6×	133 0.2×	107	3.9k
Karin Sundfeldt Sweden	30	1.3k 0.5×	606 0.5×	521 0.5×	927 1.3×	303 0.5×	91	2.7k
Dietmar Pils Austria	35	2.0k 0.7×	1.1k 0.9×	745 0.7×	373 0.5×	88 0.2×	94	3.2k
Gustavo Baldassarre Italy	40	3.4k 1.2×	1.8k 1.4×	1.6k 1.4×	245 0.3×	73 0.1×	134	5.1k

Countries citing papers authored by Rosemarie Schmandt

Since Specialization

Citations

This map shows the geographic impact of Rosemarie Schmandt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rosemarie Schmandt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rosemarie Schmandt more than expected).

Fields of papers citing papers by Rosemarie Schmandt

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rosemarie Schmandt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rosemarie Schmandt. The network helps show where Rosemarie Schmandt may publish in the future.

Co-authorship network of co-authors of Rosemarie Schmandt

This figure shows the co-authorship network connecting the top 25 collaborators of Rosemarie Schmandt. A scholar is included among the top collaborators of Rosemarie Schmandt based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rosemarie Schmandt. Rosemarie Schmandt is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Hasan, Omar, Xiaoqian Jiang, Yejin Kim, et al.. (2022). Risk of Alzheimer’s Disease Following Influenza Vaccination: A Claims-Based Cohort Study Using Propensity Score Matching. Journal of Alzheimer s Disease. 88(3). 1061–1074. 60 indexed citations

Melendez, Brenda, Sarita R. Shah, Yunyun Jiang, et al.. (2021). Novel polymer-based system for intrauterine delivery of everolimus for anti-cancer applications. Journal of Controlled Release. 339. 521–530. 5 indexed citations

Kwan, Suet‐Ying, Tsz-Lun Yeung, Ángela Rynne‐Vidal, et al.. (2020). Ubiquitin Carboxyl-Terminal Hydrolase L1 (UCHL1) Promotes Uterine Serous Cancer Cell Proliferation and Cell Cycle Progression. Cancers. 12(1). 118–118. 27 indexed citations

Yeung, Tsz-Lun, Abhinav Achreja, Hongyun Zhao, et al.. (2020). ITLN1 modulates invasive potential and metabolic reprogramming of ovarian cancer cells in omental microenvironment. Nature Communications. 11(1). 3546–3546. 39 indexed citations

Kim, Tae Hoon, Russell R. Broaddus, Rosemarie Schmandt, et al.. (2020). An immune competent orthotopic model of endometrial cancer with metastasis. Heliyon. 6(5). e04075–e04075. 7 indexed citations

Onstad, Michaela, Karen Basen‐Engquist, Rosemarie Schmandt, et al.. (2015). Omentin as a potential biomarker related to exercise and cancer risk.. Journal of Clinical Oncology. 33(15_suppl). 1571–1571. 1 indexed citations

Meyer, Larissa A., Brian M. Slomovitz, Bojana Djordjevic, et al.. (2014). The Search Continues. International Journal of Gynecological Cancer. 24(4). 713–717. 17 indexed citations

Iglesias, David A., Melinda S. Yates, Dharini van der Hoeven, et al.. (2013). Another Surprise from Metformin: Novel Mechanism of Action via K-Ras Influences Endometrial Cancer Response to Therapy. Molecular Cancer Therapeutics. 12(12). 2847–2856. 64 indexed citations

Klopp, Ann H., Yan Zhang, Travis Solley, et al.. (2011). Omental Adipose Tissue–Derived Stromal Cells Promote Vascularization and Growth of Endometrial Tumors. Clinical Cancer Research. 18(3). 771–782. 143 indexed citations

10.

Lu, Chunhua, Mian M.K. Shahzad, Myrthala Moreno‐Smith, et al.. (2010). Targeting pericytes with a PDGF-B aptamer in human ovarian carcinoma models. Cancer Biology & Therapy. 9(3). 176–182. 66 indexed citations

11.

Schmandt, Rosemarie, Anil K. Sood, Susan K. Lutgendorf, Lingegowda S. Mangala, & Guillermo N. Armaiz-Peña. (2008). 29. Exercise therapy for ovarian cancer: How does exercise counteract stress-induced tumor growth?. Brain Behavior and Immunity. 22(4). 8–8. 1 indexed citations

12.

Lü, Chunhua, Tomás Bonome, Yang Li, et al.. (2007). Gene Alterations Identified by Expression Profiling in Tumor-Associated Endothelial Cells from Invasive Ovarian Carcinoma. Cancer Research. 67(4). 1757–1768. 149 indexed citations

13.

Landen, Charles N., William M. Merritt, Lingegowda S. Mangala, et al.. (2006). Intraperitoneal delivery of liposomal siRNA for therapy of advanced ovarian cancer. Cancer Biology & Therapy. 5(12). 1708–1713. 83 indexed citations

14.

Slomovitz, Brian M., Russell R. Broaddus, Rosemarie Schmandt, et al.. (2004). Expression of imatinib mesylate-targeted kinases in endometrial carcinoma. Gynecologic Oncology. 95(1). 32–36. 26 indexed citations

15.

Oh, Jonathan C., Weiguo Wu, Guillermo Tortolero‐Luna, et al.. (2004). Increased Plasma Levels of Insulin-Like Growth Factor 2 and Insulin-Like Growth Factor Binding Protein 3 Are Associated with Endometrial Cancer Risk. Cancer Epidemiology Biomarkers & Prevention. 13(5). 748–752. 32 indexed citations

16.

Schmandt, Rosemarie, Russell R. Broaddus, Karen H. Lu, et al.. (2003). Expression of c‐ABL, c‐KIT, and platelet‐derived growth factor receptor‐β in ovarian serous carcinoma and normal ovarian surface epithelium. Cancer. 98(4). 758–764. 85 indexed citations

17.

Ramondetta, Lois M., Thomas W. Burke, Anuja Jhingran, et al.. (2003). A phase II trial of cisplatin, ifosfamide, and mesna in patients with advanced or recurrent uterine malignant mixed müllerian tumors with evaluation of potential molecular targets. Gynecologic Oncology. 90(3). 529–536. 31 indexed citations

18.

Jazaeri, Amir A., Karen H. Lu, Rosemarie Schmandt, et al.. (2003). Molecular determinants of tumor differentiation in papillary serous ovarian carcinoma. Molecular Carcinogenesis. 36(2). 53–59. 68 indexed citations

19.

Schmandt, Rosemarie, et al.. (1999). Cloning and characterization of mPAL, a novel Shc SH2 domain-binding protein expressed in proliferating cells. Oncogene. 18(10). 1867–1879. 59 indexed citations

20.

Verdi, Joseph M., Rosemarie Schmandt, Arash Bashirullah, et al.. (1996). Mammalian NUMB is an evolutionarily conserved signaling adapter protein that specifies cell fate. Current Biology. 6(9). 1134–1145. 139 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact